Quantitative analysis of MGMT promoter methylation in glioblastoma suggests nonlinear prognostic effect.
Gibson D, Ravi A, Rodriguez E, Chang S, Oberheim Bush N, Taylor J, Clarke J, Solomon D, Scheffler A, Witte J, Lambing H, Okada H, Berger M, Chehab F, Butowski NA.
Gibson D, et al. Among authors: scheffler a.
Neurooncol Adv. 2023 Sep 19;5(1):vdad115. doi: 10.1093/noajnl/vdad115. eCollection 2023 Jan-Dec.
Neurooncol Adv. 2023.
PMID: 37899778
Free PMC article.